Back
Relay Therapeutics Stock Price Chart
Sponsored
RLAY
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
RLAY
Relay Therapeutics
Last Price:
7.50
Seasonality Move:
-6.15%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- The current trend is moderately bearish and RLAY is experiencing slight selling pressure.
Relay Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.7 | Sell |
20-day SMA: | 7.38 | Buy |
50-day SMA: | 7.61 | Sell |
200-day SMA: | 8.22 | Sell |
8-day EMA: | 7.67 | Sell |
20-day EMA: | 7.51 | Sell |
50-day EMA: | 7.41 | Buy |
200-day EMA: | 8.21 | Sell |
Relay Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 50.32 | Buy |
Chaikin Money Flow: | -577574 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.56 - 8.08) | Buy |
Bollinger Bands (100): | (6.41 - 8.05) | Buy |
Relay Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Relay Therapeutics Stock
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 7.50 while RLAY 8-day simple moving average is 7.70, which is a Sell signal.
- The stock price of RLAY is 7.50 while Relay Therapeutics 20-day SMA is 7.38, which makes it a Buy.
- Relay Therapeutics 50-day simple moving average is 7.61 while RLAY share price is 7.50, making it a Sell technically.
- RLAY stock price is 7.50 and Relay Therapeutics 200-day simple moving average is 8.22, creating a Sell signal.
RLAY Technical Analysis vs Fundamental Analysis
Sell
33
Relay Therapeutics (RLAY)
is a Sell
Is Relay Therapeutics a Buy or a Sell?
-
Relay Therapeutics stock is rated a Sell
The current Relay Therapeutics [RLAY] share price is $7.50. The Score for RLAY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Relay Therapeutics Stock Info
Market Cap:
1B
Price in USD:
7.50
Share Volume:
1.73M
Relay Therapeutics 52-Week Range
52-Week High:
12.14
52-Week Low:
5.70
Sell
33
Relay Therapeutics (RLAY)
is a Sell
Relay Therapeutics Share Price Forecast
-
What is the Relay Therapeutics stock price today?
The Relay Therapeutics stock price is 7.50 USD today. -
Will RLAY stock go up or go down?
Relay Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Relay Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relay Therapeutics is overvalued.
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 7.50 while RLAY 8-day exponential moving average is 7.67, which is a Sell signal.
- The stock price of RLAY is 7.50 while Relay Therapeutics 20-day EMA is 7.51, which makes it a Sell.
- Relay Therapeutics 50-day exponential moving average is 7.41 while RLAY share price is 7.50, making it a Buy technically.
- RLAY stock price is 7.50 and Relay Therapeutics 200-day simple moving average is 8.21, creating a Sell signal.
Fundamental Analysis of Relay Therapeutics
Is Relay Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.03 per share, and a decrease next year of $0.24 per share.
Technical Analysis of Relay Therapeutics
Should I short Relay Therapeutics stock?
- RLAY Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Relay Therapeutics is a Buy
- Relay Therapeutics Relative Strength Index (RSI) is 50.32, which suggest Relay Therapeutics is overbought
- The Bollinger Bands (25) for Relay Therapeutics is (6.56 - 8.08), which suggest Relay Therapeutics is a Buy
- The Bollinger Bands (100) for Relay Therapeutics is (6.41 - 8.05), which suggest Relay Therapeutics is a Buy
* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.